跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 35,239 条关于
“activated PI3Kδ syndrome”
全部
35,239
临床试验
30,542
药物
908
机构
19
资讯
3,770
前天
Pharming Group Reports Positive Phase II Topline Data for Leniolisib in PIDs
7个月前
Pharming Advances Rare Disease Pipeline with Napazimone for Mitochondrial Disease and Leniolisib Expansion
去年
Pharming Group Initiates Phase II Trial of Leniolisib for Primary Immunodeficiencies
11个月前
Pharming Group to Present 12 Studies on Rare Disease Treatments at 2025 ACAAI Meeting
去年
Novel PI3Kδ Inhibitor Roginolisib Shows Promise in Phase 2 Trial for Metastatic Uveal Melanoma
去年
MHRA Approves Joenja (leniolisib) as First Treatment for Rare Immune Disease APDS
去年
Chiesi Farmaceutici's Inhaled PI3Kδ Inhibitor Suggests Target Unsuitability for COPD Management
11个月前
FDA Grants Priority Review for Leniolisib in Children with Rare Immunodeficiency APDS
去年
Chiesi's Inhaled PI3Kδ Inhibitor CHF-6523 Shows Limited Clinical Benefit in COPD
2年前
iOnctura Secures €80 Million Series B to Advance PI3Kδ Cancer Therapy Through Phase II Trials
第 1 页,共 377 页
上一页
下一页